Research analysts at UBS Group initiated coverage on shares of Baxter International (NYSE:BAX – Get Rating) in a note issued to investors on Tuesday, The Fly reports. The brokerage set a “neutral” rating on the medical instruments supplier’s stock. BAX has been the topic of a number of other research reports. Cowen reduced their target […]